Eric Ribner | executive |
John Gillard | executive |
Des Fitzgerald | executive |
James Sidoti | analyst |
Greetings, and welcome to the Trinity Biotech First Quarter 2024 Earnings Call.
[Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Eric Ribner, Investor Relations for Trinity Biotech. Thank you.
You may begin.